Cargando…

Impact of acetylcholinesterase inhibitors on the occurrence of acute coronary syndrome in patients with dementia

The study aimed to investigate the association of acetylcholinesterase inhibitors (AChEIs) use with the risk of acute coronary syndrome (ACS). We conducted a population-based retrospective cohort study of dementia patients during 1 January 1999 to 31 December 2008 using the National Health Insurance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ping-Hsun, Lin, Yi-Ting, Hsu, Po-Chao, Yang, Yi-Hsin, Lin, Tsung-Hsien, Huang, Chia-Tsuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649673/ https://www.ncbi.nlm.nih.gov/pubmed/26577589 http://dx.doi.org/10.1038/srep15451

Ejemplares similares

Association between acetylcholinesterase inhibitors and risk of stroke in patients with dementia
por: Lin, Yi-Ting, et al.
Publicado: (2016)

Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review
por: Pozzi, Federico Emanuele, et al.
Publicado: (2022)

Reassessing blood acetylcholinesterase in dementia
por: Han, Pengcheng
Publicado: (2015)

Dementia post-radiotherapy: improvement with acetylcholinesterase inhibitor. A case report
por: Damin, Antonio Eduardo, et al.
Publicado: (2009)

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
por: Walczak-Nowicka, Łucja Justyna, et al.
Publicado: (2021)

Association between long-term usage of acetylcholinesterase inhibitors and lung cancer in the elderly: a nationwide cohort study
por: Liu, Chien-Ting, et al.
Publicado: (2022)

Template-Based de Novo Design for Type II Kinase Inhibitors and Its Extended Application to Acetylcholinesterase Inhibitors
por: Su, Bo-Han, et al.
Publicado: (2013)

Predictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease
por: Hsu, Po-Chao, et al.
Publicado: (2012)

Intranasal administration of acetylcholinesterase inhibitors
por: Costantino, Henry R, et al.
Publicado: (2008)

Acetylcholinesterase inhibitors attenuate angiogenesis
por: Miyazaki, Ryohei, et al.
Publicado: (2012)

Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
por: Čolović, Mirjana B, et al.
Publicado: (2013)

Production of the Acetylcholinesterase Inhibitor from Yarrowia lipolytica S-3
por: Lee, Dae-Hyung, et al.
Publicado: (2008)

The Behavioral Effects of Combination Therapy of Memantine and Acetylcholinesterase Inhibitors Compared with Acetylcholinesterase Inhibitors Alone in Patients with Moderate Alzheimer’s Dementia: A Double-Blind Randomized Placebo-Controlled Trial
por: Youn, HyunChul, et al.
Publicado: (2021)

Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: A meta-analysis
por: Kim, Jin Ok, et al.
Publicado: (2020)

White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer’s disease
por: Lee, Li-Hua, et al.
Publicado: (2023)

Clinical utility of mean platelet volume and immature platelet fraction in acute coronary syndrome
por: Huang, Hsien-Li, et al.
Publicado: (2019)

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
por: Lu, Shin-Hua, et al.
Publicado: (2011)

Coronary Collateral Circulation in Patients of Coronary Ectasia with Significant Coronary Artery Disease
por: Hsu, Po-Chao, et al.
Publicado: (2014)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
por: Mehta, Mona, et al.
Publicado: (2012)

Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
por: Pohanka, Miroslav
Publicado: (2014)

Musical Hallucinations Treated with Acetylcholinesterase Inhibitors
por: Blom, Jan Dirk, et al.
Publicado: (2015)

Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias – A narrative review
por: Huang, Yichang, et al.
Publicado: (2020)

Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review
por: Ruangritchankul, Sirasa, et al.
Publicado: (2021)

Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia
por: García-Alberca, José María, et al.
Publicado: (2022)

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
por: Bittner, Nadine, et al.
Publicado: (2023)

Ages of hepatocellular carcinoma occurrence and life expectancy are associated with a UGT2B28 genomic variation
por: Le, Puo-Hsien, et al.
Publicado: (2019)

Primary Investigation for the Mechanism of Biatractylolide from Atractylodis Macrocephalae Rhizoma as an Acetylcholinesterase Inhibitor
por: Xie, Yong-Chao, et al.
Publicado: (2016)

Higher risk of dementia in primary Sjogren's syndrome
por: Hou, Tsung‐Yun, et al.
Publicado: (2019)

Adverse outcomes of abrupt switch and discontinuation of acetylcholinesterase inhibitors in dementia with Lewy bodies: Case report and literature review
por: Greiman, Tristyn L., et al.
Publicado: (2019)

Reduction of Circulating Endothelial Progenitor Cell Level Is Associated with Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary and Peripheral Interventions
por: Chiang, Chia-Hung, et al.
Publicado: (2014)

Dynamics of the Acetylcholinesterase Tetramer
por: Gorfe, Alemayehu A., et al.
Publicado: (2008)

QSAR analysis on tacrine-related acetylcholinesterase inhibitors
por: Wong, Kai Y, et al.
Publicado: (2014)

Comedication and Treatment Length in Users of Acetylcholinesterase Inhibitors
por: Sverdrup Efjestad, Anne, et al.
Publicado: (2017)

An Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population: A Population-Based Case-Control Study
por: Shih, Hsin-I, et al.
Publicado: (2015)

Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in Taiwan
por: Lin, Po-Lin, et al.
Publicado: (2023)

Natural Antioxidants, Tyrosinase and Acetylcholinesterase Inhibitors from Cercis glabra Leaves
por: Lou, Yueyue, et al.
Publicado: (2022)

Influence of high-density lipoprotein cholesterol on coronary collateral formation in a population with significant coronary artery disease
por: Hsu, Po-Chao, et al.
Publicado: (2013)

Discovery selective acetylcholinesterase inhibitors to control Tetranychus urticae (Acari: Tetranychidae)
por: Wang, Jiachen, et al.
Publicado: (2023)

Caregivers’ perspectives and experiences of withdrawing acetylcholinesterase inhibitors and memantine in advanced dementia: a qualitative analysis of an online discussion forum
por: Parsons, Carole, et al.
Publicado: (2019)

Impact of impaired glomerular filtration rate and revascularization strategy on one-year cardiovascular events in acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry
por: Lin, Tsung-Hsien, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2v20cggl9cmbg79naf1vg49pip